Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors

NCT07348042 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

198

Enrollment

OTHER

Sponsor class

Conditions

Tumor, Solid

Interventions

DRUG: RGL-270 Injection
DRUG: Adebelimab Injection

Sponsor

Xian-Jun Yu